Projects funded by the NCN

A triple agonist of glucagon, GLP-1, and GIP receptors as a novel therapeutic option for the treatment of heart failure ...

Call: SONATA 20 , Panel: NZ5

Principal investigator: dr Marta Katarzyna Oknińska

Centrum Medyczne Kształcenia Podyplomowego

Neuroprotective effect of SGLT2i: direct influence on amyloid-β related pathology

Call: PRELUDIUM 22 , Panel: NZ7

Principal investigator: Agnieszka Pawlos

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Mechanisms and therapeutic potential of SGLT2/SGLT1 and NHE-1 inhibition in a rat model of heart failure with preserved ...

Call: OPUS 23 , Panel: NZ5

Principal investigator: dr hab. Urszula Mackiewicz

Centrum Medyczne Kształcenia Podyplomowego

Pharmacogenomics of SGLT2 inhibitors - investigating the role of empagliflozin in epigenetic modification of non-coding ...

Call: PRELUDIUM 21 , Panel: NZ7

Principal investigator: Anna Nowak-Szwed

Warszawski Uniwersytet Medyczny